{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:43:41Z","timestamp":1791899021220,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,28]]},"DOI":"10.7759\/cureus.24563","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T18:26:19Z","timestamp":1651170379000},"source":"Crossref","is-referenced-by-count":7,"title":["The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Rohit","family":"Rangroo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaival","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schepcoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olu","family":"Oyesanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2900","article-title":"Extrapulmonary onset manifestations of COVID-19","volume":"76","author":"Finsterer J","year":"2021","unstructured":"Finsterer J, Scorza FA, Scorza CA, Fiorini AC. Extrapulmonary onset manifestations of COVID-19. Clinics (Sao Paulo). 2021, 76:e2900. 10.6061\/clinics\/2021\/e2900","journal-title":"Clinics (Sao Paulo)"},{"key":"ref2","unstructured":"COVID live update. 244,702,870 cases and 4,968,075 deaths from the coronavirus - Worldometer. (2021). Accessed: October 25, 2021: http:\/\/www.worldometers.info\/coronavirus\/?utm_campaign=homeAdvegas1?. Published 2021. Accessed October 25, 2021."},{"key":"ref3","unstructured":"COVID data tracker. (2021). Accessed. October 25, 2021: https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395:507-13. 10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2006\/862797","article-title":"Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays","volume":"13","author":"Zahariadis G","year":"2006","unstructured":"Zahariadis G, Gooley TA, Ryall P, et al.. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Can Respir J. 2006, 13:17-22. 10.1155\/2006\/862797","journal-title":"Can Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104941","article-title":"Microbial co-infections in COVID-19: associated microbiota and underlying mechanisms of pathogenesis","volume":"156","author":"Hoque MN","year":"2021","unstructured":"Hoque MN, Akter S, Mishu ID, et al.. Microbial co-infections in COVID-19: associated microbiota and underlying mechanisms of pathogenesis. Microb Pathog. 2021, 156:104941. 10.1016\/j.micpath.2021.104941","journal-title":"Microb Pathog"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury L","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020, 81:266-75. 10.1016\/j.jinf.2020.05.046","journal-title":"J Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens DM","year":"2008","unstructured":"Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008, 198:962-70. 10.1086\/591708","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis","volume":"10","author":"Klein EY","year":"2016","unstructured":"Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, Dugas A. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016, 10:394-403. 10.1111\/irv.12398","journal-title":"Influenza Other Respir Viruses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202004.0077.v2","article-title":"The pathophysiology of virulence of the COVID-19","author":"Hakim S","year":"2020","unstructured":"Hakim S, Boyd F, Angel de Soto J. The pathophysiology of virulence of the COVID-19. Preprints.org. 2020, 10.20944\/preprints202004.0077.v2","journal-title":"Preprints.org"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02799-1","article-title":"Severe COVID-19 in the intensive care unit: a\u00a0case series","volume":"15","author":"Hariyanto H","year":"2021","unstructured":"Hariyanto H, Yahya CQ, Aritonang RC. Severe COVID-19 in the intensive care unit: a\u00a0case series. J Med Case Rep. 2021, 15:259. 10.1186\/s13256-021-02799-1","journal-title":"J Med Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita N","year":"2006","unstructured":"Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006, 45:419-28. 10.2169\/internalmedicine.45.1691","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00023","article-title":"Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis","volume":"7","author":"Narita M","year":"2016","unstructured":"Narita M. Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol. 2016, 7:23. 10.3389\/fmicb.2016.00023","journal-title":"Front Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01212-12","article-title":"Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence","volume":"81","author":"Gro\u00dfhennig S","year":"2013","unstructured":"Gro\u00dfhennig S, Schmidl SR, Schmeisky G, Busse J, St\u00fclke J. Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence. Infect Immun. 2013, 81:896-904. 10.1128\/IAI.01212-12","journal-title":"Infect Immun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02113442","article-title":"Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection","volume":"14","author":"Fournier S","year":"1995","unstructured":"Fournier S, Bastuji-Garin S, Mentec H, Revuz J, Roujeau JC. Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 1995, 14:558-9. 10.1007\/BF02113442","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5765","article-title":"Insights into the pathogenesis of Mycoplasma pneumoniae (Review)","volume":"14","author":"He J","year":"2016","unstructured":"He J, Liu M, Ye Z, et al.. Insights into the pathogenesis of Mycoplasma pneumoniae (Review). Mol Med Rep. 2016, 14:4030-6. 10.3892\/mmr.2016.5765","journal-title":"Mol Med Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00562","article-title":"Body mass index and prognosis of COVID-19 infection. A systematic review","volume":"11","author":"Peres KC","year":"2020","unstructured":"Peres KC, Riera R, Martimbianco AL, Ward LS, Cunha LL. Body mass index and prognosis of COVID-19 infection. A systematic review. Front Endocrinol (Lausanne). 2020, 11:562. 10.3389\/fendo.2020.00562","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115477","article-title":"Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: surfing the first wave","volume":"101","author":"Ruiz-Basti\u00e1n M","year":"2021","unstructured":"Ruiz-Basti\u00e1n M, Falces-Romero I, Ramos-Ramos JC, de Pablos M, Garc\u00eda-Rodr\u00edguez J. Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: surfing the first wave. Diagn Microbiol Infect Dis. 2021, 101:115477. 10.1016\/j.diagmicrobio.2021.115477","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93180-the-severity-of-the-co-infection-of-mycoplasma-pneumoniae-in-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:37Z","timestamp":1707507517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93180-the-severity-of-the-co-infection-of-mycoplasma-pneumoniae-in-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.24563","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}